Published in Aust N Z J Psychiatry on September 18, 2012
The power of neuroimaging biomarkers for screening frontotemporal dementia. Hum Brain Mapp (2014) 1.00
Neuroimaging predictors of brain amyloidosis in mild cognitive impairment. Ann Neurol (2013) 0.81
Striatal Atrophy in the Behavioural Variant of Frontotemporal Dementia: Correlation with Diagnosis, Negative Symptoms and Disease Severity. PLoS One (2015) 0.76
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci (1986) 18.17
Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol (2001) 9.96
Neurodegenerative diseases target large-scale human brain networks. Neuron (2009) 9.69
Dynamics of gray matter loss in Alzheimer's disease. J Neurosci (2003) 7.03
Frontal-subcortical circuits and human behavior. Arch Neurol (1993) 5.61
Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res Brain Res Rev (2000) 5.45
The primate basal ganglia: parallel and integrative networks. J Chem Neuroanat (2003) 5.16
Mapping hippocampal and ventricular change in Alzheimer disease. Neuroimage (2004) 5.07
Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol (2011) 4.98
Hippocampal morphometry in schizophrenia by high dimensional brain mapping. Proc Natl Acad Sci U S A (1998) 3.72
Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol (2010) 3.47
Evidence for segregated and integrative connectivity patterns in the human Basal Ganglia. J Neurosci (2008) 3.43
Synaptic organisation of the basal ganglia. J Anat (2000) 3.12
Parametric estimate of intensity inhomogeneities applied to MRI. IEEE Trans Med Imaging (2000) 3.09
Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology (2004) 2.81
Alzheimer's disease: striatal amyloid deposits and neurofibrillary changes. J Neuropathol Exp Neurol (1990) 2.78
Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.30
Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Hum Brain Mapp (2009) 2.28
Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.25
Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal. Neurobiol Aging (2008) 2.25
Large deformation diffeomorphism and momentum based hippocampal shape discrimination in dementia of the Alzheimer type. IEEE Trans Med Imaging (2007) 2.24
The limbic lobe and its output channels: implications for emotional functions and adaptive behavior. Neurosci Biobehav Rev (2005) 2.05
Regional specificity of brain atrophy in Huntington's disease. Exp Neurol (1998) 2.02
Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study. Brain (2008) 2.02
TRANS-SYNAPTIC RETROGRADE DEGENERATION IN THE VISUAL SYSTEM OF PRIMATES. J Neurol Neurosurg Psychiatry (1963) 2.02
Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen (2008) 2.00
Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study. Brain (2009) 1.93
Fronto-striatal connections in the human brain: a probabilistic diffusion tractography study. Neurosci Lett (2007) 1.86
Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res Bull (2010) 1.79
Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study. Neuroimage (2006) 1.72
Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease. J Nucl Med (2009) 1.70
Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology (2005) 1.56
Frontotemporal dementia as a frontostriatal disorder: neostriatal morphology as a biomarker and structural basis for an endophenotype. Aust N Z J Psychiatry (2012) 1.53
Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN. Neurology (2009) 1.48
High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types. Arch Neurol (2009) 1.45
The effect of neurodegenerative diseases on the subventricular zone. Nat Rev Neurosci (2007) 1.28
Statistical analyses of brain surfaces using Gaussian random fields on 2-D manifolds. IEEE Trans Med Imaging (2007) 1.27
Huntington disease models and human neuropathology: similarities and differences. Acta Neuropathol (2007) 1.25
The basal ganglia: an overview of circuits and function. Neurosci Biobehav Rev (2007) 1.23
Synaptic depression and aberrant excitatory network activity in Alzheimer's disease: two faces of the same coin? Neuromolecular Med (2009) 1.21
The molecular basis of frontotemporal dementia. Expert Rev Mol Med (2009) 1.12
3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjects. Neurobiol Aging (2010) 1.10
Caudate nucleus volumes in frontotemporal lobar degeneration: differential atrophy in subtypes. AJNR Am J Neuroradiol (2008) 1.07
Volumetrics of the caudate nucleus: reliability and validity of a new manual tracing protocol. Psychiatry Res (2008) 0.99
Magnetic resonance imaging in frontotemporal dementia shows subcortical atrophy. Dement Geriatr Cogn Disord (2008) 0.99
Subcortical and deep cortical atrophy in Frontotemporal Lobar Degeneration. Neurobiol Aging (2009) 0.97
Putaminal volume in frontotemporal lobar degeneration and Alzheimer disease: differential volumes in dementia subtypes and controls. AJNR Am J Neuroradiol (2009) 0.96
Shape alterations in the striatum in chorea-acanthocytosis. Psychiatry Res (2011) 0.95
The NUCOG: validity and reliability of a brief cognitive screening tool in neuropsychiatric patients. Aust N Z J Psychiatry (2006) 0.94
Selective dendritic degeneration of medium spiny neurons in dementia with Lewy bodies. Neurology (2006) 0.93
Striatal morphology as a biomarker in neurodegenerative disease. Mol Psychiatry (2012) 0.88
Shape analysis of the neostriatum in subtypes of frontotemporal lobar degeneration: neuroanatomically significant regional morphologic change. Psychiatry Res (2011) 0.87
Shape analysis of the neostriatum in frontotemporal lobar degeneration, Alzheimer's disease, and controls. Neuroimage (2010) 0.84
Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy--results from the TRACK-HD study. J Neurol Sci (2011) 0.83
Shape abnormalities of the striatum in Alzheimer's disease. J Alzheimers Dis (2011) 0.83
Morphometric analysis of subcortical structures in progressive supranuclear palsy: In vivo evidence of neostriatal and mesencephalic atrophy. Psychiatry Res (2011) 0.81
Proliferation and differentiation of adult endogenous neural stem cells in response to neurodegenerative process within the striatum. Neurodegener Dis (2006) 0.80
Caudate nucleus volumes in stroke and vascular dementia. Psychiatry Res (2009) 0.77
Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A (2004) 17.86
Mapping cortical change across the human life span. Nat Neurosci (2003) 8.98
Longitudinal mapping of cortical thickness and brain growth in normal children. J Neurosci (2004) 7.30
PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med (2006) 6.02
Sexual dimorphism of brain developmental trajectories during childhood and adolescence. Neuroimage (2007) 5.86
Mapping brain asymmetry. Nat Rev Neurosci (2003) 4.99
Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet (2003) 4.91
The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol (2010) 4.59
Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. Neuroimage (2006) 3.85
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
Dynamics of the hippocampus during encoding and retrieval of face-name pairs. Science (2003) 3.67
Mapping brain maturation. Trends Neurosci (2006) 3.60
Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects. Neuroimage (2008) 3.40
Computer-assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurol (2003) 3.26
Sex differences in cortical thickness mapped in 176 healthy individuals between 7 and 87 years of age. Cereb Cortex (2006) 3.23
Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update. Mol Genet Metab (2012) 3.19
Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol (2006) 3.11
Brain structure and obesity. Hum Brain Mapp (2010) 3.04
Genus zero surface conformal mapping and its application to brain surface mapping. IEEE Trans Med Imaging (2004) 2.93
Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative. Alzheimers Dement (2010) 2.88
Mapping changes in the human cortex throughout the span of life. Neuroscientist (2004) 2.86
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans. Alzheimers Dement (2010) 2.79
3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease. Brain (2006) 2.73
Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder. Lancet (2003) 2.71
3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry. Neuroimage (2006) 2.69
Mapping cortical thickness and gray matter concentration in first episode schizophrenia. Cereb Cortex (2004) 2.66
The topography of grey matter involvement in early and late onset Alzheimer's disease. Brain (2007) 2.53
Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment. Neuroimage (2005) 2.51
Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch Gen Psychiatry (2005) 2.48
Genetics of brain fiber architecture and intellectual performance. J Neurosci (2009) 2.42
3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. Neuroimage (2008) 2.40
Hashimoto's encephalopathy : epidemiology, pathogenesis and management. CNS Drugs (2007) 2.39
Towards multimodal atlases of the human brain. Nat Rev Neurosci (2006) 2.37
Neuroimaging endophenotypes: strategies for finding genes influencing brain structure and function. Hum Brain Mapp (2007) 2.36
Statistical properties of Jacobian maps and the realization of unbiased large-deformation nonlinear image registration. IEEE Trans Med Imaging (2007) 2.33
Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.30
Senescence rates are determined by ranking on the fast-slow life-history continuum. Ecol Lett (2008) 2.30
Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects. Neuroimage (2009) 2.28
Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Hum Brain Mapp (2009) 2.28
Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry (2007) 2.27
Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.25
Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal. Neurobiol Aging (2008) 2.25
Neurobiology of intelligence: science and ethics. Nat Rev Neurosci (2004) 2.22
Robust brain extraction across datasets and comparison with publicly available methods. IEEE Trans Med Imaging (2011) 2.22
Dynamic mapping of normal human hippocampal development. Hippocampus (2006) 2.21
Medical comorbidity in schizophrenia. Med J Aust (2003) 2.20
Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull (2005) 2.13
Boosting power for clinical trials using classifiers based on multiple biomarkers. Neurobiol Aging (2010) 2.13
A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci U S A (2010) 2.12
Surface-constrained volumetric brain registration using harmonic mappings. IEEE Trans Med Imaging (2007) 2.11
Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia. Proc Natl Acad Sci U S A (2002) 2.10
Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. Neuroimage (2009) 2.03
Genetics of brain structure and intelligence. Annu Rev Neurosci (2005) 2.02
Extracting and Representing the Cortical Sulci. IEEE Comput Graph Appl (1999) 2.01
Substitution Monotherapy With Levetiracetam vs Older Antiepileptic Drugs: A Randomized Comparative Trial. Arch Neurol (2012) 1.99
Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology (2010) 1.98
A Hough transform global probabilistic approach to multiple-subject diffusion MRI tractography. Med Image Anal (2011) 1.98
Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr Res (2009) 1.98
Genetics of white matter development: a DTI study of 705 twins and their siblings aged 12 to 29. Neuroimage (2010) 1.96
Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease. Neuroimage (2010) 1.94
Evidence for deficient modulation of amygdala response by prefrontal cortex in bipolar mania. Psychiatry Res (2007) 1.93
Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coils. Neuroimage (2007) 1.93
Lifespan trajectory of myelin integrity and maximum motor speed. Neurobiol Aging (2008) 1.92
Diffusion imaging, white matter, and psychopathology. Annu Rev Clin Psychol (2011) 1.91
A genome-wide association study identifies five loci influencing facial morphology in Europeans. PLoS Genet (2012) 1.91
Regional specificity of hippocampal volume reductions in first-episode schizophrenia. Neuroimage (2004) 1.87
Relationships between IQ and regional cortical gray matter thickness in healthy adults. Cereb Cortex (2006) 1.87
Reduced neocortical thickness and complexity mapped in mesial temporal lobe epilepsy with hippocampal sclerosis. Cereb Cortex (2006) 1.87
Neuroanatomical abnormalities in schizophrenia: a multimodal voxelwise meta-analysis and meta-regression analysis. Schizophr Res (2011) 1.81
Comparison of AdaBoost and support vector machines for detecting Alzheimer's disease through automated hippocampal segmentation. IEEE Trans Med Imaging (2009) 1.80
Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet (2012) 1.79
Multi-site genetic analysis of diffusion images and voxelwise heritability analysis: a pilot project of the ENIGMA-DTI working group. Neuroimage (2013) 1.78
Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials. Neuroimage (2012) 1.76
Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology (2005) 1.76
Mapping corpus callosum deficits in autism: an index of aberrant cortical connectivity. Biol Psychiatry (2006) 1.75
Regional brain shape abnormalities persist into adolescence after heavy prenatal alcohol exposure. Cereb Cortex (2002) 1.74
Common Alzheimer's disease risk variant within the CLU gene affects white matter microstructure in young adults. J Neurosci (2011) 1.74
Mapping sulcal pattern asymmetry and local cortical surface gray matter distribution in vivo: maturation in perisylvian cortices. Cereb Cortex (2002) 1.73
Pituitary volume in psychosis. Br J Psychiatry (2004) 1.70
Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis. Arch Gen Psychiatry (2009) 1.70
3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiol Aging (2010) 1.70
Abnormal cortical thickness and brain-behavior correlation patterns in individuals with heavy prenatal alcohol exposure. Cereb Cortex (2007) 1.69
Mapping Alzheimer's disease progression in 1309 MRI scans: power estimates for different inter-scan intervals. Neuroimage (2010) 1.69
Obesity is linked with lower brain volume in 700 AD and MCI patients. Neurobiol Aging (2010) 1.69
Automated ventricular mapping with multi-atlas fluid image alignment reveals genetic effects in Alzheimer's disease. Neuroimage (2007) 1.68
Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. Am J Psychiatry (2003) 1.67
Neuroanatomy of fragile X syndrome is associated with aberrant behavior and the fragile X mental retardation protein (FMRP). Ann Neurol (2008) 1.66
Multi-source feature learning for joint analysis of incomplete multiple heterogeneous neuroimaging data. Neuroimage (2012) 1.66
Three-dimensional patterns of hippocampal atrophy in mild cognitive impairment. Arch Neurol (2006) 1.65
Three-dimensional brain growth abnormalities in childhood-onset schizophrenia visualized by using tensor-based morphometry. Proc Natl Acad Sci U S A (2008) 1.65
Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls. Neuroimage (2009) 1.63